Docetaxel - Sun PharmaAlternative Names: DOCEFREZ
Latest Information Update: 22 Jul 2015
At a glance
- Originator Sun Pharmaceutical Industries
- Class Antineoplastics; Small molecules; Taxanes
- Mechanism of Action Mitosis inhibitors; Tubulin modulators; Tubulin polymerisation promoters
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Breast cancer; Non-small cell lung cancer; Prostate cancer
Most Recent Events
- 19 Jul 2013 Biomarkers information updated